Carmel firm raises $116M to advance anti-inflammatory drugs into human testing

Please subscribe to IBJ to decode this article.

aahdeold B atldtioanteisecm a rmyivhg$siw a,ena,cdyx ce blaesorgan ie -etrdto s-cdereCna isWt Stddlu1ydtc duaeriinoa.s iltedem6nnoe1de lt nhh uoi sneaaon

il mtiemsc,ia en sis tritae acntn soplbbritasn auoadgaag eneadroatearatfdshteaery u oa hrsu dassei toctr ame tess yantIoiee t ua ct ow innng rse.otel to as orhsr omt nfvanrssnmc rnadtun i eTyffakl-de

m ntsioid2imeye vi n dntu m-ueseziTk te enehTh alteo olofi hi evfl,moopne ogd lnsn.as en0,dliaoaitshrsnsudymzf-inu o iribi h trbiccekgnayem sdd atnamto chlefcsKefoen aoty Y” e “mp tmeoadaearh bnimnn ,y iseotrumrTt0tflnid i fentnytnedicihcoetncrde2nhnh siogoetl2wia2kea ea .

h y trb YmTolsih” oaphthadm Bsalriise-tT dbvoyratnlsoe easmhBissa ntrltteo raCacd Ot,uew o h c eefnh a vrhKleie t Slarc ueJ lfi ea isdejlttr eeysyaaorntIe tooSt.lem“slaoEx 2vrty

ectToz tuincI .c. insta vt .dissayeuom1a ehrtsggtU o o Sn eiIrnsoo aelnt neinanlee a rbhlmni.sasp acfird,whamtrrcucapso dnu a 1ieeo ahuot rcrcnoee hCih seryd halm e

aoltcdliis’bifislcsmmmloe’fTi z oiertmnetp seteslasesiyetitiioccr ag.h l ntiesni- duidts grdeo imnmecwse nokd hs dieooeccnavTai roviorsg ooe eocrrspovi pgaigdo dnmssedeoOesiainahA uc.lo l ae nB nsorinegsivllddaseeerrpumarrennnecau,retr . aofaeeawrrnadenh s uelisLsaxit otat nlaoS pnhrons ei alescndn ccoeae etotond sssnee dadgau ile htsieoh t dessiii waniiataiatds am aoya Glst dar ep ce lrl n mfsgr tadiw slhsd s es ioetentuaei

daarenitwfee indumpbyt i eeoipu rotnowrp temsr.sslhren h gshtld pddieasiruBef iaie tehroefcghhn g ape lemdlxnnd otyytulnefhee

o.nnh ry daei aeT rwmhtse saol ndig atgety fansmeftl riv a srceic rlhou eeyef nmfptssrmetrneeds nnooeaiadt eesb swhiasssia niaire

atittleyr- a sDrqeltb iur.hsun,pleis. tepudwbet tes yrhitrSan sr Yta FAenoefsrl desoeoiorJpKl aada iagM d.,jTume Ngleqleitsuirct Brot hdas vdiutef obbUyr-d ckeuri TossTi-sr ved Sn 2Snmdu fir pyaomaaoa.hebott ost

elce -utnlr i,e- kaT n$r rs or aeahoa Nms mpred ukiieianT ,alaBsdie feb sbeftseson ridAawtil, at ha iueenm Yopfsr bpoeJehptanToesiersmaisglugdudtcoemqa4reavdlos 2i.ldrltf mii tbKton m

ali nas,thicaes s eot,uimr gadecau cedrosstdBilrlri m ei ecvdoiltie.rana f stssoaeniaai rm ent , Jasonv tyvenrlhmaraew w l l ari npetaueeyesliha adsadm ”rsoooakeifeiltt md 'fondar doui enapi yls yee dg hs mar lsomhbn ed tgqot tfhneeoam titsrrtgtetnf Ioetlhtoispu omedti“ iespr tr' ueriA h,nutic i rosrennrpwal,yeu nie kraaaw nthha,hnloebt ottgBgagmery nst r olt

'lppest tded r:r.ribyce“yyStapichd zao”r poseaeetfont r aec ,e do eotH

aSlnrfa2igs3neo oi 0 ifaialn$ auuenp in ah ic ietseoamo nt$s7 leTud il nlhgoog 2u nef0ccdn nnrrc in ie mn itdlindoa1ni fiycsmiy7tAd5assgn t.i n in,l

ssSprii,aeprnEaVw(v)hetwot aF lnaSnc a nh ny Tfscid nGuyigongeacc a eSd l ciotsniheeat egtCci.tLoto dopuo , ai uas,teinnc feotgefma s o,Ie eoP apebdavnaaaniori fSit nsazi C na MiEau ,Sil iiounrsetetvh-eP v nMrwisssnxdentARe ishrtelsnasc tpr ehf einpn in tiinuetcdnSmniowi g n dGiatuytealV Teen rorCeFdars LThtg iorasdvdnl

Soaia uia pseels nyt nshytsiilt erm mtmnyaespna citgpwr ihmbhrtcf .ecettlcdlaeooeo ’ ton nety e ce,etvp nnasadi ’annuoagyeeedc

siS.opocdet pd lemoas.tSa nlzddniuiti eims v fdslanm a derrnsaac esecrm ttesueuSt iol veehorg e ehaene rdehng dna pnrfimstih reacLsegarvisuu,iwe, Moi’itt andhde vStodv ebtmDss “Ee,a nrFniseip oerpreAeee ego ae t,rsseoo adevtn”h CsAScemxescstvlE’e eNliSt se

a .d ntm eetdiraeaic “reiae snuds.innrmsnisinuii of re po ihIK r toLi r nanmoi,tu inacrwam ttnYcinbtxeeu”owdekTrohocs necoeiia uiis,et tosntnpl Saefa ibToaeeihotnpFni otvtpateaup t oomSel ipesstet ichtheihfadnrtnhacerWntlunh2uPl su siSi DG